Similarly, the cellular proliferation was decreased in the same condition (Fig. 5I and J), suggesting that the combined treatment of GLUT3 siRNA or miR-3189 remarkably reduced these metabolic changes and cellular proliferation in HDAC2 knockdown GBM cells. This evidence concerns the gene HDAC2 and glioblastoma.